Worldwide Kidney Biopsy Market Synopsis and Highlights, Key Findings, Major Companies Analysis and Forecast to 2023

“rnKidney Biopsy Market”
Market Research Future has a half cooked research report on the global kidney biopsy market. Kidney Biopsy: Increasing Demand for The New Diagnostic Procedure for Kidney Diseases Boost The Market Growth

Kidney biopsy is a commonly used diagnostic procedure for kidney diseases which is of two major types namely percutaneous biopsy and surgical biopsy. It is also used to monitor the kidney condition during kidney transplant and to determine complications if any. The healthcare provider may recommend kidney biopsy if the patient is diagnosed with kidney disease or identifies the presence of blood in the urine.

Increasing awareness about early diagnosis of kidney diseases and rising demand for technologically advanced medical devices for diagnosis and treatment of chronic diseases including kidney failure drive the global kidney biopsy market.

The global kidney biopsy market is expected to grow at a CAGR of ~5.2% during the forecast period 2017-2023.

Get a sample report at https://www.marketresearchfuture.com/sample_request/5309 .

Key Players

Some of key the players in the market are Boston Scientific Corporation (U.S.), Cook Medical (U.S.), C R Bard, Inc. (U.S.), Devicor Medical Products Inc. (U.S.), Hologic Inc. (U.S.), Intact Medical Corporation (U.S.), Precision Biopsy, LLC, Scion Medical Technologies LLC (U.S.),, Integra LifeSciences Corporation (U.S.), Creganna (U.S.), Focal Therapeutics, Inc. (U.S.), CareFusion (U.S.), Argon Medical Devices, Inc. (U.S.)and others.

Regional Analysis

The Americas kidney biopsy market is expected to show extensive growth owing to the increasing number of patient population with kidney diseases and technological advancement in the healthcare sector. Moreover, high healthcare spending and increasing government support for research & development will boost the market growth. Additionally, kidney disease is one of the major cause of mortality and morbidity in the Americas, thus boosting the market growth. According to the National Kidney Foundation, in 2016, nearly 82% patients in the U.S. were waiting for a kidney transplant, although a number of effective treatments are available in the market. Additionally, in 2016, over 2 million people underwent a kidney transplant or dialysis in the U.S.

In Europe, Germany, France, and the U.K are the major markets for kidney biopsy. The growth of the market in Europe is attributed to increasing use of diagnostic services in tertiary care centers, extensive research and development activities in the field of urology, and the emergence of new market players in the medical device industry.

Asia Pacific is the fastest growing kidney biopsy market across the globe owing vast progress of healthcare industries in major economies such as Japan, China, and India along with rising prevalence of chronic diseases such as diabetes, obesity, and high blood pressure. Japan holds a major share of the regional market due to the availability of technology, increasing healthcare spending, and increasing government initiatives for research. India is the hub of diabetic population in Asia Pacific region exhibiting extensive growth opportunities in the market.

The Middle East & Africa hold the least share of the global market due to limited availability of medical facilities. The United Arab Emirates, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market whereas, the African region is expected to witness a moderate growth.

Browse Complete Report at https://www.marketresearchfuture.com/reports/kidney-biopsy-market-5309 .

Intended Audience

  • Research and Development (R&D) Companies
  • Ambulatory Care Centers
  • Academic Institutes and Universities
  • Biotechnology Companies
  • Medical Device Manufacturers
  • Medical Device Suppliers
  • Market Research and Consulting Service Providers
  • Potential Investors

As per the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), kidney disease is often referred to as a “silent disease” as there are no symptoms in its early stages and can go undetected. Chronic kidney disease (CKD) is a global health burden and a risk factor for cardiovascular disease (CVD). High blood pressure and diabetes are the main causes of CKD.

Increasing number of biopsy procedures and rising demand for new techniques for diagnosis of chronic diseases are the major drivers for the growth of the market. Additionally, increasing prevalence of kidney diseases and rising need for the better diagnostic and treatment methods drive the growth of the market. Established market players in the developed countries lead the globalization by offering new products and services to the developing countries and emerging economies. However, the high cost of diagnostic services may hinder the market growth during the forecast period.

 More Inquire at https://www.marketresearchfuture.com/enquiry/5309 .

Europe is the second largest market for kidney biopsy whose growth is attributed to an increasing emphasis on the development of new diagnostic devices in urology, rising government support for research & development, and availability of funds for research. Rising number of specialty services offered by various healthcare providers in Europe also accelerate the growth of the market. Furthermore, favorable reimbursement policies, increased application and significant investments in the development of new technologies for the treatment of diseases will fuel the market growth during the forecast period. 

Asia Pacific is the fastest growing kidney biopsy market owing to the ever-increasing prevalence of diabetes, and rising number of kidney transplant procedures in urology centers. Rapidly developing healthcare technology sector and high healthcare expenditure also drive the market. Furthermore, increasing demand for quality devices in the healthcare is expected to lead the use of advanced equipment, which, in turn, may speed up the market growth in this region.

However, the Middle East & Africa holds the least share of the kidney biopsy market due to less availability of funds, limited medical facilities, and unavailability of technologically advanced medical devices. In the Middle East, the United Arab Emirates (U.A.E) is the largest market owing to the progress of healthcare industry.

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/kidney-biopsy-market-5309